BioCentury
ARTICLE | Finance

IPO queue grows as Seaport, Hemab line up NASDAQ offerings

Volatility risk may be abating; Kailera, Alamar propose terms

April 13, 2026 10:29 PM UTC

After weeks of inactivity, the queue of biotechs hoping to list on NASDAQ has begun to grow again.

According to a pair of prospectuses filed late Friday, neuropsychiatric start-up Seaport Therapeutics Inc. and coagulation disorders company Hemab Therapeutics Holdings Inc. are each looking to raise cash in IPOs...